Webinars
Risk Made Real: An Evidence-Based Approach to Addressing Risk in Contraception
Dates this webinar will be offered:
This is an internet-based activity that should take 1 hour to complete.
To participate in this webinar learners should:
- Take the pretest
- Listen to webinar
- Take the post-test
- Complete follow-up evaluation survey
Learning Objectives
At the conclusion of this presentation, participants should be able to:
- Assess factors that influence patients’ perceptions of risk
- Define absolute risk, attributable risk, relative risk, and odds ratio
- Explain the differences, advantages, and disadvantages of descriptive studies, observational studies, and prospective studies
- Demonstrate effective risk communication strategies
Accreditation Information
Physicians: The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. ARHP designates this educational activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Others: A certificate of attendance will be issued indicating that this activity is accredited for a maximum of 1 hour of AMA PRA Category 1 CreditTM.
Sponsoring Information
This program is sponsored by the Association of Reproductive Health Professionals.
Funding Information
This project is funded through an educational grant from Merck & Co.
Disclosure Information
All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.
Target Audience
The intended audiences for this activity are health professionals who provide reproductive health services, including physicians, nurse practitioners, nurse-midwives, physician assistants, educators, researchers, and other professionals who work in obstetrics/gynecology, family medicine, and related fields.
Advisory Committee Disclosures
|
Jeffrey Jensen, MD, MPH (Course Director/Instructor)
Consultant for Bayer HealthCare Pharmaceuticals, Agile, Merck & Co., HRA Pharma, Population Council; Speaker for Bayer HealthCare Pharmaceuticals; Research funds from NICHD, Population Council, Bayer HealthCare Pharmaceuticals, Med360
Anne Moore, DNP, APRN, FAANP (Instructor/Peer Reviewer)
Merck & Co. Implanon/Nexplanon trainer |
Sarah Prager, MD, MAS (Planner)
Merck & Co. Implanon/Nexplanon trainer
David Turok, MD, MPH (Planner/Instructor)
Consultant for Bayer HealthCare Pharmaceuticals; Research funds from Med360
James Trussell, PhD (Planner/Instructor)
Consultant for Bayer HealthCare Pharmaceuticals Economics Health Group Berlin |
ARHP Staff/Consultant Disclosures
|
Aleya Horn Kennedy, MPP
Program Manager
Nothing to disclose
Carole Chrvala, PhD
Consultant (Medical Writer)
Nothing to disclose |
Beth Jordan, MD
Medical Director
Nothing to disclose
Amy Swann, MA
Vice President
Nothing to disclose |
Back
|